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NO VEINS, NO PAIN

Interventional radiologists at Mallinckrodt
Institute offer an effective procedure to treat
the unsightly and painful varicose veins that
affect millions of Americans—endovenous
laser ablation, a less invasive alternative to
the traditional surgical treatment.

A PROMISING NEW TOOL FOR TRACKING
MULTIPLE SCLEROSIS

Researchers in the Biomedical Magnetic Resonance
Laboratory are working to devise a method for
determining injury to the myelin sheath around
nerves, which could have a profound impact on
predicting the future course of multiple sclerosis
and other neurodegenerative diseases.

TAKING BREAST CANCER DIAGNOSIS
AND TREATMENT FORWARD

SPOT NEWS

Mallinckrodt Institute is part of a nationwide
National Cancer Institute clinical trial to determine
whether digital mammography is as effective as or
better than standard film-based mammography in
the early detection of breast cancer.

32 YEARS OF OUTSTANDING CONTRIBUTIONS

In 1957 Fred Hodges became a part of medical
history when Mallinckrodt Institute became
the first facility in the United States to offer
neuroradiology services, then a promising addition
to the field of radiology.

ON THE COVER Dione Farria, MD, of the Institute's Breast Imaging section, is

Visit the MIR web site at
www.mir.wustl.edu

Washington University's principal investigator for an important study to evaluate
digital mammography. Photograph by Tim Parker

SPOT NEWS
MIR has
best doctors

Bhalla named
Teacher of the
Year

■

Since 1985 diagnostic
radiology senior residents
annually have honored an
MIR faculty member who
has made outstanding
contributions to resident
education, by teaching not
only with a traditional
course study but through
example as the residents
observe and participate in
the interpretation of clinical
studies. At the annual residents' and fellows' farewell
dinner in June, Sanjeev
Bhalla, MD, assistant professor of radiology, was named
the MIR Teacher of the Year.
Bhalla came to
Mallinckrodt Institute in
1995 as a first-year diagnostic radiology resident. He
completed the residency
(chief resident, 1998-1999)
and a fellowship in chest
radiology. He has been

Once again, Mallinckrodt Institute physicians
were included in the list of
"Best Doctors in St. Louis,"
as reported in the August
2003 issue of St Louis Magazine. The 433-member list
was excerpted from The
Best Doctors in America
database, which includes
approximately 30,000 doctors in more than 40 medical
specialties. Best Doctors
asks thousands of physicians
worldwide for nominations
to the list, based on patient
care rather than academic or
research excellence.
actively involved in resident education since
joining the MIR faculty in
2000 and currently serves
as assistant director of the
Diagnostic Radiology
Residency Program.
At the dinner, James
Goddard, MD, clinical
neuroradiology fellow, was
presented with the Fellow
of the Year award. The
following MIR faculty
were honored as Distinguished Teachers:
• Robert McKinstry, MD,
PhD, assistant professor
of radiology
• Christine Menias, MD,
assistant professor of
radiology
• William Middleton, MD,
professor of radiology
• Franz Wippold, MD,
associate professor of
radiology and chief of
neuroradiology.

Nuclear Medicine
Farrokh Dehdashti, MD
Keith Fischer, MD
Robert Gropler, MD
Tom MiUer, MD, PhD
Mark Mintun, MD
Henry Royal, MD
Barry Siegel, MD
Radiation Oncology
Perry Grigsby, MD
JeffMichalski, MD
Robert Myerson, MD, PhD
Joseph Simpson, MD, PhD
Marie Taylor, MD
Radiology
Claire Anderson, MD
DeWitte Cross, MD
Michael Darcy, MD
Jay Heiken, MD
David Hovsepian, MD
William McAlister, MD
William Middleton, MD
Barbara Monsees, MD
Christopher Moran, MD
Daniel Picus, MD
David Rubin, MD
Stuart Sagel, MD
Marilyn Siegel, MD
William Totty, MD
Thomas Vesely, MD
Franz Wippold, MD

Faculty
elected to
leadership
roles
Mallinckrodt Institute
faculty were recognized f(
their outstanding contribv
tions to and excellence in
medical field.
JeffMichalski, MD, a
ciate professor of radiatic
oncology and chief of the \
Radiation Oncology Clinica;
Division, was inducted as a v
fellow in the American College of Radiology (ACR) at the
May 2003 Annual Meeting in
Washington, DC. Fellowship
is one of the highest honors
conferred by the ACR, with
only about 10 percent of the
32,000 radiologists, radiation
oncologists, interventional
radiologists, and medical
physicists who comprise the
membership being selected
for fellowship.
David Piwnica-Worms,
MD, PhD, professor of radiology and of molecular biology
and pharmacology and chief
of the molecular radiopharrmcology laboratory, is the 20032004 president of the Society
for Molecular Imaging (SMI),
an international scientific
organization. As president,
Piwnica-Worms will host the
SMI third annual meeting to
be held September 9-12, 2004
in St. Louis.
Henry Royal, MD, profec sor of radiology, was elected
the 2003-2004 president of th i
Society of Nuclear Medicine
(SNM). The society, now in i s
50"' year, promotes the benei
rial uses of radioisotopes an'
radiation, disseminates new
ideas in nuclear medicine, an I
stresses the interdisciplinary
nature of nuclear science. As
SNM president, Royal also
serves on the society's Boarc
of Directors.

MALLINCKRODT INSTITUTE OF RADIOLOGY

Siegel receives
SNM award

Frank Wilson,
MD, ARS
president, and
Carlos Perez,
MD (right)

Another honor
for Perez
In April 2003, Carlos
Perez, MD, professor of radiation oncology and chair of
the Department of Radiation
Oncology, received the
American Radium Society's
(ARS's) Janeway Medal in
recognition of his outstanding scientific contributions.
The award and associated
lecture was established in
1933 in memory of Henry
Janeway, MD, a pioneer in
the therapeutic use of
radium. The medal was presented to Perez in April 2003
at the ARS Annual Meeting
in Houston, Texas.
Perez, one of the most
highly regarded radiation
oncologists in the world,
advocates the treating of
patients' emotional and
psychological needs as well
as their physical needs.
He has made important
contributions to the clinical
management of patients,
especially those with gynecologic tumors and carcinoma of the prostate and of
the breast.
He has received
numerous honors, including
Gold Medal awards from the
American College of Radiol-

ogy (ACR), the American
Society for Therapeutic
Radiology and Oncology, and
CRILA/Circulo do Radioterapeutas Ibero-Latinoamericanos. Perez is a trustee of
the American Board of
Radiology, a member of
the National Board of the
American Cancer Society,
and an ACR fellow.
Perez joined the MIR
faculty in 1964 and was
named director of the Radiation Oncology Center in 1976.
During this time, he initiated
a training program for radiation therapy technologists
and established the Cancer
Information Center (CIC), the
first resource facility of its
kind. The CIC became a role
model for similar centers
in the United States and
abroad. In June 2001, he was
named chairman of Washington University's newly
formed Department of
Radiation Oncology.

Michael Welch, PhD, a past
recipient of the de Hevesy
Award, presented the 2003
award to Barry Siegel, MD
(right).
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Barry Siegel, MD, professor of radiology and of medicine, and chief of the Division
of Nuclear Medicine, received
the prestigious Georg Charles
de Hevesy Nuclear Pioneer
Award at the Society of Nuclear
Medicine Annual Meeting in
June 2003. The award is presented annually for distinguished contributions to the
specialty of nuclear medicine.
Established in 1960, the
award honors de Hevesy, a
1943 recipient of the Nobel
Prize in chemistry.
Siegel is widely recognized
for his clinical and scientific
expertise and is often called
upon as a consultant to governmental organizations, industry,
medical centers, and universities. A distinguished clinician
and scientist, Siegel has investigated various applications of
nuclear medicine, from
diagnosing thrombosis and pulmonary embolism to detecting
myocardial infarction, and is
now focusing on the use of
positron emission tomography
(PET) in cancer detection.
MIR's Division of Nuclear
Medicine was one of the first
facilities to transition PET from
research to clinical practice.
He is an internationally
recognized expert in the clinical
uses of radiopharmaceuticals
and serves as chairman of the
Radiopharmaceuticals Expert

Committee of the United
States Pharmacopeia Council
of Experts, and on advisory
committees to the Food
and Drug Administration
and the Nuclear Regulatory
Commission.

Wilson Award
presented
At Washington University's May commencement,
Daniel Hatfield received the
35th Annual Hugh M. Wilson
Award for Meritorious Work in
Radiology. Established in 1968
as a tribute to Hugh Wilson,
MD, the second MIR director,
the award historically is presented to a fourth-year medical
student who has performed
outstanding work in basic or
clinical radiological sciences.
As part of his elective
research rotation, Hatfield
worked with Kyongtae Bae,
MD, PhD, assistant professor
of radiology, as a member of
Bae's research team studying
radiological imaging for polycystic kidney disease. The
research is part of a large, multicenter National Institutes of
Health-sponsored trial and was
Hatfield's first exposure to
modern methods of image
segmentation, manipulation,
and analysis. After becoming
familiar with the different kidney measurement algorithms
used in the study, Hatfield
developed two new measurement algorithms employing
3-D imaging software.
Bae was impressed with
Hatfield's intelligence, work
ethic, productivity, and
resourcefulness. "It was a great
pleasure to mentor a medical
student who is researchminded and knowledgeable
about many subjects, including
mathematics, medicine,
physiology, and radiology."
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no Veins, no Pain

BY

ANNE

KESSEN

LOWELL

so

There is new hope for millions of
Americans whose severe varicose
veins discouraged them from donning a bathing suit this summer—
or worse, who spent many an
afternoon inside, elevating their
gams to gain temporary relief from
painful symptoms. Endovenous
laser ablation is an easy, nearly
painless procedure that treats
varicose veins. Endovenous laser
ablation offers several advantages
over traditional surgical treatment
of varicose veins: It is a much
shorter procedure, uses only a local
anesthetic, and is more effective.
Patients can resume normal activities immediately after the procedure
and more strenuous exercise, such
as running or lifting, within one
week. The technique received FDA

What causes varicose veins?
Symptomatic varicose veins—
larger and more painful than
common surface (or spider)
veins— affect about 26 million
Americans. The large size and
ungainly appearance have earned
this class of varicose veins adjec-

We are looking forward to helping varicose
vein sufferers in the St. Louis area address a
painful and frequently embarrassing condition.
approval in February of 2002 and is
becoming widely used in the United
States. Endovenous laser ablation is
performed at MaUinckrodt Institute
of Radiology at Washington University Medical Center by interventional radiologists whose particular
training and expertise in catheterguided procedures and use of ultrasound guidance systems make them
well suited to meet the demands of
the new technique. Michael Darcy,
MD, professor of radiology and chief
of interventional radiology, and
Suresh Vedantham, MD, assistant
professor of radiology, lead
MaUinckrodt Institute's development
of this promising minimally invasive procedure.
Left: The fiberoptic laser is inserted into the
thin catheter.
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tives such as "ropy," "wormy," and
"knotted." Women are afflicted
with varicose veins in far greater
numbers than are men. These veins
are more common with age-half of
women in the over-50 age bracket
suffer from symptomatic varicose
veins. Risk factors include standing
in place for long periods, family
medical history, and pregnancy.
Retail and factory workers, security guards, and others who stand
for hours without a break are
especially susceptible to the development of severe varicose veins.
Unlike smaller surface veins
that are typically repaired solely for
cosmetic reasons, true varicose
veins are not just unsightly. Not all
people with varicose veins will
have symptoms; for others, the
veins can cause discomfort. Aches,

Suresh Vedantham, MD, explains the procedure to
Karen Seifert.

itching, night cramps, fatigue, and
sensations of heaviness or restlessness in the affected leg are a daily
fact of life for many with this
condition. In some cases, varicose
veins can lead to chronic venous
insufficiency, which in turn can
cause leg swelling, eczema,
changes in skin pigmentation,
and ulceration.
The saphenous vein, a large
blood vessel running from ankle to
groin, is the usual culprit in severe
varicose vein disease. The saphenous vein transports blood from
the deep veins in the calf and thigh
back to the heart. In a healthy vein,
blood flows upward toward the
heart, assisted by one-way valves
in the vein that prevent gravity
from reversing the flow. However,
if the valves weaken, blood leaks
down and pools (or refluxes) in the
veins in the lower leg. Eventually
these veins bulge with the pressure
of the excess blood. As the condition worsens, the veins become
varicose. From the Latin varix,
varicose is aptly defined as "abnormal dilatation or enlargement of a
blood vessel, especially accompanied by tortuous development."

no Veins, no Pain
Standard treatment
Treatment of the saphenous vein,
the underlying cause of varicose
veins, is the only effective and lasting
solution to the problem. "Underlying
pressure in the saphenous vein must
be addressed to cure symptomatic
varicose veins," emphasizes Darcy.
"Until recently, surgery was the only
option available. Because it is a
painful procedure with a long
recovery period, many people opt
to do nothing and continue to
suffer painful symptoms."

disorders, skin infections, or blood
clotting disease; and pregnant
women. Add to that a 30 percent rate
of recurrence and the potential for
lasting scars, and you have a procedure begging for improvement.

A safer, faster alternative
With endovenous laser ablation, patients with varicose veins
who have endured discomfort and
embarrassment finally have an
alternative to the long, often
bumpy surgical road to treatment

Patients can resume normal activities immediately
after the procedure and more strenuous exercise,
such as running or lifting, within one week.
Home remedies and lifestyle
changes-such as weight reduction
and increased exercise—are ineffective for many people with severe
varicose veins. And while tube-shaped
compression stockings—thick, hot,
itchy and far from fashionable-are
helpful in relieving some of the pain
associated with varicose veins, they
are not usually sufficient to completely eliminate symptoms.
Surgical nomenclature for the
treatment of varicose veins may
be enough to make patients queasy:
The procedure is dubbed "vein stripping." Under general anesthesia, the
surgeon removes the offending vein
through a series of incisions. Discomfort, bruising, and numbness in the
leg are common postsurgical adverse
effects. Time to full recovery can be
two to three weeks, and patients cannot return to normal everyday activity
for a week following surgery. The
surgical option is not appropriate for
a large subset of patients, including
the elderly; people with circulatory

and recovery. Ablation means to
take away, to remove. Endovenous
indicates that the procedure takes
place inside the vein, where the laser
works its magic. "This procedure
offers several benefits," says Darcy.
"It is a noninvasive procedure that
deals with the root cause of varicose
veins by addressing the saphenous
vein. Patients we've treated have
told us it is virtually painless. And
early reports indicate a dramatic
improvement in recurrence rates
over that of surgery."
In a comfortable outpatient
setting, a local anesthetic is applied
to the vein itself. Through a tiny
dot-sized incision, which the
patient feels as a pinprick, a thin
catheter is placed into the saphenous vein. Using ultrasound
imaging, the interventional radiologist follows the catheter's position.
A tiny fiberoptic laser is inserted
through the catheter. At the end of
the saphenous vein, the radiologist
releases laser energy and slowly
pulls the laser back through the
catheter, applying heat to the walls

of the diseased vein. The resulting
thermal effect causes the vein to
collapse, putting it out of the bloodflow business. With the saphenous
vein closed, healthy veins pick up
the slack and transport blood flow
in the leg in a normal fashion.
Although vascular surgeons,
dermatologists, and plastic surgeons are also performing this new
procedure, interventional radiologists are ideally suited to carry out
laser ablation. "Interventional radiologists pioneered catheter-based
treatment methods, and we have
the most experience in ultrasound
guidance for minimally invasive
procedures," says Vedantham.
Forty minutes after entering
the procedure room, the patient is
ready to go home, with nothing
more than a Band-Aid® to show for
the experience. Over-the-counter
pain relievers may be used to
address minor leg soreness. Most
patients resume normal routine
immediately and more strenuous
activity within a week. Many
patients will opt to return to the
office for cosmetic treatment of
any smaller, accessory veins that
may linger after treatment of the
saphenous vein. This follow-up
requires only surface laser treatment or sclerotherapy (a simple
injection that causes the offending
veins to shrivel and disappear).

Study documents success
In the summer of 2003 the first
long-term study of laser treatment
for varicose veins validated its
advantages over surgery. In a study
of nearly 500 patients treated with
laser ablation, radiologists at Weill
Cornell Vascular in New York City
(where the procedure was developed) documented a 98 percent
success rate and recurrence of less
than seven percent over two years
following treatment. Vein stripping,

MALLINCKRODT INSTITUTE OF RADIOLOGY
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Varicose Veins
in contrast, results in recurrence
in about 25 percent of patients.
Although skin burns and nerve
damage are theoretical risks of
laser treatment, none of the
patients in the Cornell study—
and no Mallinckrodt Institute
patients—encountered either complication. The procedure has not
yet been approved to treat varicose
veins in the posterior area of the
calf, because of the proximity to
small nerves located in that area.
But Darcy is optimistic that
eventually it will be perfected to
treat varicose veins located anywhere in the leg.
Endovenous laser ablation is a
cost-effective procedure, at less
than half the cost of vein stripping,
and patients do not have to take
time off from work to recover. With
the release of positive clinical data,
the procedure may soon be widely
covered by insurance.
"We are looking forward to
helping varicose vein sufferers in
the St. Louis area address a painful
and frequently embarrassing condition. This is what we do—catheter
guided procedures and ultrasound," says Darcy. "It's exciting to
combine our skills with breakthrough medical technology to
serve so many patients." Dm
Editor's Note: Doctors Darcy and
Vedantham are performing this
laser procedure in the Center for
Advanced Medicine, a new
outpatient facility at the corner of
Forest Park Boulevard and Euclid
Avenue. Convenient parking
garages are just across the street.
If you have varicose veins, call
314-362-2900 to schedule a free
consultation with a physician.

Varicose veins occur in varying degrees in their appearance
and severity of symptoms, largely dependent on the size of the
vein affected. Different levels of treatment are available to
meet the individual needs of each patient. The first line of attack
against any type of varicose vein disease is to make lifestyle changes:
maintain a healthy weight, exercise (especially walking or running),
elevate legs while resting, and wear elastic support stockings.
Spider veins are the smallest and least symptomatic type of varicose vein, so called because of the thin, web-like appearance of the veins.
Spider veins may occur on the face as well as on the legs but are not
raised or bumpy as are larger varicose veins. Spider veins can be treated
with sclerotherapy or laser treatment. Sclerotherapy is a simple procedure—a solution is injected into the vein and causes the vein walls to
swell and stick together, eventually closing shut. In a short time, the vein
turns to scar tissue and is no longer visible. Sclerotherapy requires no
anesthesia, is performed in a doctor's office, and has few adverse effects.
However, recurrence is common—some veins may require several treatments to eliminate them, and the procedure cannot prevent spider veins
from cropping up in new places. Laser treatment for spider veins is also
relatively painless and easy, performed in the office without anesthesia.
Laser light is directed at the surface of the skin, along the course of the
vein. However, like sclerotherapy, laser treatments may need to be
repeated to be 100 percent effective, and laser treatment does not
prevent new spider veins from forming.
For medium-sized varicose veins, a procedure called ambulatory
phlebectomy may be effective. These veins are frequently very unsightly
and may cause painful symptoms. Ambulatory phlebectomy can be done
under local or general anesthetia, and most patients can return to normal
activity the next day. To remove the vein, the physician makes several
incisions in the skin, pulls the vein until it breaks,
and removes it in pieces. Like vein stripping, this
procedure may cause pain, bruising, and scarring
(although to a lesser degree than the stripping
procedure).
Large, deep varicose veins can be addressed
with surgical vein stripping or the less invasive
laser surgery. Large varicose veins are most likely
to cause painful and irritating symptoms, in addition to being unsighuy. Surgical treatment must be
done under general anesthesia and may keep
patients from their normal routine for up to three
weeks; laser treatment requires only a local anesthetic, has few adverse effects and lower recurrence, and has a recovery period of about 24 hours.

Michael Darcy, MD
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Multiple sclerosis
(MS) is an alltoo-common neurological
disorder, affecting some
400,000 Americans.

Its

basic mechanism is clear:
Above: MR images of human spinal cord,
obtained by using DTI. Left, top and

A person's immune system

bottom: patients with MS; right (top and
bottom): patients without the disease. Top

mistakenly identifies the

row: relative anistropy (variation) maps;
bottom: thoracic vertebra (T2W) images.

body's own nerve tissue as

Left: Victor Song, PhD, (left) and

foreign and attacks it,

Joseph Ackerman, PhD, are in the
positron emission tomography (PET)
facility used to image small animals.

causing

inflammation.

Eventually, the fatty myelin
sheath that acts as a kind
of insulator around those
nerves is injured, along
with the nerve fibers or
axons themselves.
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Most patients develop a relapsingremitting form of the disease, in which
flare-ups alternate with long periods of
remission. Others have primary-progressive or progressive-relapsing MS,
marked by steadily increasing disability from the outset.
To predict the future course of the
disease, it is crucial to know whether
the myelin or the axon has been damaged, and how much damage has taken
place. A myelin injury is also more
treatable than axonal injury, which is
not currently reversible. And these
same questions pertain to spinal cord
injuries, Alzheimer's disease, and a
host of neurodegenerative diseases.
"While MS is considered a
demyelinating disease, some people
now think that axonal injury may
occur early in the disease process. But
nobody knows for sure, because you
need a noninvasive method to study
the brain in a patient with MS," says
Sheng-Kwei ("Victor") Song, PhD,
assistant professor of radiology.
In 1999, Song first became interested in solving this problem through
the use of an exciting new method
called diffusion tensor magnetic resonance imaging (DTI). Since then, his
research has had promising results:
five articles (two articles published in
the scientific journal Neuroimage
addressed white matter injury with
MS-related mouse models), several
grants, and encouraging preliminary
findings (culminating this year in a
major collaborative grant with colleagues in radiology, neurology, biomedical engineering, pharmacology,
and biophysics).
"If this method succeeds, the
biggest impact will be actually seeing
what type of injury has taken place, so
the physician can decide what to treat
and how to treat it," says Song. "This
method can also be used to see how
effective that treatment is."

At first, scientific journals were
reluctant to accredit his
research. One after another turned
down his work because some reviewers were skeptical about such findings. Finally, in 2002, after a year
of trying, Neuroimage published
Song's study.
Next, he proceeded to further
validate the method, using a mouse
model with retinal ischemia, which
causes damage to the optic nerve. In
this model, the axonal degeneration
precedes demyelination in the optic
nerve of the injured eye. Song and a
research team noninvasively examined the mice after the injury to establish the time course of white matter
degeneration after injury to the eye.
Imaging of MS began in the early
1980s with the advent of magnetic
resonance imaging (MRI), which is
routinely used to pinpoint lesions in
the brains of patients with MS. But
MRI cannot define whether the damage affects the myelin or the axons.
Song, who received his doctoral
degree and also did his postdoctoral
training at Washington University,
wondered whether DTI might help
clarify this picture.
After conferring with Anne
Cross, MD, Department of Neurology, Song decided to use DTI on a
biologically unusual form of a mouse
(known as "shiverer" mice, which

MR image (using DTI): optic nerves of patient
without MS.

Doctors John Russell, Anne Cross, and Victor Song

are born without the myelin sheath
around their axons) to address the
question about using DTI to define
white matter pathology in the brain
of a patient with MS. A pilot grant
from the National Multiple Sclerosis
Society, as well as grants from Washington University and the National
Science Council of Taiwan, supported his work.
Song's findings were encouraging. In the shiverer mice, water diffusion perpendicular to the axonal
fibers (radial diffusion) was significantly higher than diffusion in a
group of age-matched controls.
However, the water diffusion parallel
to the axonal fibers (axial diffusion)
was unchanged in the shiverer mice,
whose axons were intact. Song
concluded, as he said in an article
based on this research, that these
findings "may potentially be used to
differentiate myelin loss versus
axonal injury."

Their findings supported those of
Song's hypothesis: Axonal and
myelin degeneration can be detected
and differentiated noninvasively using
in vivo DTI. This time, the reception
of his work was quite different.
Neuroimage accepted his paper
immediately, with publication
scheduled for November 2003.
"We showed that by using DTI
we could predict how early the
axonal degeneration started and
when the demyelination took place.
Further, we could see all this in vivo
without removing the eye or nerve,
which was very exciting," says Song.
The next step, he says, is to test
this concept on human volunteers.
Success in mice is a hopeful sign but
not conclusive, since a mouse system
is much simpler than the complex
human anatomy. To begin work on
this new study, he has again collaborated with neurologist Anne Cross,
molecular biologist John Russell, and
chemist Joseph Ackerman, Song's
former mentor in Washington
University's doctoral program.

f
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Together, the investigators
applied for one of three Collaborative
MS Research Center Awards, granted
in 2003 by the National Multiple
Sclerosis Society, to continue this
research. The five-year award of
$825,000 supports scientists and
clinicians from various fields working
together on MS-related problems.
Song also received another National
MS Society Research Grant of
$497,000 to further support his
work in this area
Using animal models at first, and
then human volunteers, they
will focus on the problem of optic
neuritis, an early symptom of MS in
which patients temporarily—and
sometimes permanently—lose their
sight. Through a friend who has MS
and has developed optic neuritis, Song
has heard firsthand how difficult and
frightening it can be.
"If we can determine whether
injury involves axons or myelin, then
perhaps we can look at the optic

nerve when patients experience their
first onset of optic neuritis to see
how severely the nerve is injured.
We may be able to tell whether the
cause is demyelination or some other
reversible process, or we may be able
to say whether the problem will get
better or worse," says Song.
While this work continues, Song
is also advancing along parallel lines
in other diseases. With a pilot grant
from the Alzheimer's Disease
Research Center and a two-year
research contract from Pfizer Inc.,
he is looking at the process of neurodegeneration in Alzheimer's
disease. Currently he is using a
mouse model to develop technologies for studying white matter
degeneration to the spinal cord.
In the Collaborative MS Research
Center grant, the investigators will
work toward creating DTI profiles of
injury to tissue, differentiating underlying tissue damages and repair in
MS brain lesions. "I believe that in
two to three years, we will either
prove or disprove the feasibility of using this method
in humans," says Song. "I
want to be optimistic and
say that we will be able to
prove it works or at least
will work on some system
of the body, such as the
optic nerve. If we can do
that, it would be a great
accomplishment." EU
Editor's Note: For more information about MS, visit the National
Multiple Sclerosis Society at
wurw.nmss.org or the Multiple
Sclerosis Foundation at
www.msfacts. org.
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COMMON
SYMPTOMS OF MS
Each person is affected differently by MS.
Some of the more common symptoms of this
disease are listed below.
Mobility impairment, including loss of balance,
muscle coordination, partial or complete paralysis
Impaired vision
Bladder and bowel problems
Joint stiffness and/or pain
Abnormal fatigue
Sensory changes
Swallowing difficulty
Speech problems
Cognitive difficulties

RESEARCH
COLLABORATORS
Joseph Ackerman, PhD, departments of
Chemistry and of Radiology
Chen Chang, PhD, Institute of Biomedical
Sciences, Academia Sinica, Taiwan
Anne Cross, MD , Department
of Neurology
Won-Kyu Ju, PhD, Department of
Ophthalmology and Visual Sciences
Shiow-Jiuan Lin, MS, Department
of Medicine
Arthur Neufeld, PhD, Department
of Ophthalmology and Visual Sciences
Michael Ransbottom, BS, Department
of Neurology
John Russell, PhD, Department
of Molecular Biology and Pharmacology
Sheng-Kwei ("Victor") Song, PhD,
Department of Radiology
Shu-Wei Sun, Ph, Department of Radiology

Clinical trials taking

breast Cancer diagnosis
and treatment fowa^ »»>

Women facing the staggering diagnosis of brea<
cancer have a rosier outlook, thanks to advances
in breast imaging and clinical trials.
Jill Bokern, RN, is the nurse
coordinator in the Breast Health
Center at Washington University
Medical Center. Because she
worked there and was due for her
annual screening mammogram, she
thought she would participate in a
clinical trial comparing traditional
film-screen mammography with
digital mammography. "Why not
participate in a study if you qualify?
This one is not painful or inconvenient. We all know that no imaging,
including mammography, is one
hundred percent, so if we can finetune our diagnostic techniques,
why not?"

Early Detection Still the Best
According to the American
Cancer Society (ACS), there is no
question that finding a breast cancer early while asymptomatic
increases the likelihood it will be
relatively small and will not have
spread beyond the breast. The best
way to do that, says the ACS, is by
a combination of the use of mammography, clinical breast exam by
a health professional, and regular
breast self-exam. The ACS guidelines, updated this year, recommend that women in their 20s and
30s have a clinical breast exam by a
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health professional as part of their
regular check-ups every three
years, and that breast self-exam
(BSE) should be an option for
women starting in their 20s. After
age 40, women should have a
breast exam by a health professional every year, and should begin
yearly screening mammograms.

Jill Bokern, RN, a breast cancer
survivor and an advocate of
screening mammography.

breast Cancer diagnosis
wflreatment
Advanced age is no reason to stop
regular mammograms, as long as
the woman is in good health and a
candidate for treatment. The ACS
states that mammograms can miss
some cancers, but they remain an
effective and valuable tool for early
treatment and survival.
As a nurse/health educator, I
both preached and followed that
advice. Thirteen years ago, I sought
out my doctor when I discovered a
lump during a regular breast selfexam. The resulting clinical mammogram came back negative.
Because of that, I delayed followup until the lump became too large
to be treated by lumpectomy.
Had some of the newer technology, such as digital mammography been around then, would my
initial diagnosis and treatment have
been different? That, in essence, is
what the DMIST study is trying to
determine. DMIST stands for the
Digital Mammographic Imaging
Screening Trial. Funded by the
National Cancer Institute and conducted by the American College of
Radiology Imaging Network
(ACRIN), the purpose of this clinical trial is to determine whether
digital mammography is as good as
or better than the standard filmbased mammography.
Dione Farria, MD, MPH, assistant professor of radiology, is the
principal investigator for the Washington University study site. "We
must find out if the technology is
new or if it's new and better, especially when it costs four to five
times more than the standard
screen-film mammography. The
industry has done well explaining
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"Improving health starts with prevention
and how physicians communicate with
patients every step of the process."
and marketing the digital equipment even before clinical trials.
Radiology and health care facilities
are already replacing old screen
film equipment with the digital, so
it's important to know if it is indeed
better technology."
Digital Mammography
From the woman's perspective,
digital mammography is done
much in the same way as the traditional screen film mammogram,
including the same breast positioning and compression. The main difference is that the mammogram
can be interpreted on a computer
instead of on film, allowing for
image enhancement, magnification
and manipulation.
Earlier studies on the use of
digital versus screen-film mammography had some problems, according to several critics, such as size,
enrollment bias and the use of only
one type of digital equipment. Size
of the study is important to obtain
enough suspicious mammograms
to truly evaluate the differences.
Enrollment bias in the earlier
smaller studies came about
because those women in the study
already had an abnormal or suspicious screen-film mammogram.
Because of that, the studies could
not be used to prove that digital

For a complete screening mammogram, it is important
to have both mediolateral oblique and craniocaudal
views. The white spots on this 45-year-old woman's
mammograms indicate benign calcifications.
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mammography could find cancers
undetectable on screen film mammography. There were also concerns that radiologists were biased,
knowing the enrollment requirement of an abnormal film-screen
mammogram. Using participants
with no anticipation of cancer and
enrolled for routine screening is
thought to be the only way to
objectively compare the two forms
of mammography.
The DMIST study has a goal of
49,500 participants in the United
States and Canada. Says Farria,
"We now have about forty-one
thousand women enrolled across
the thirty-five sites. Washington
University has twenty-seven hundred patients in the study, and we
are stiU recruiting." The DMIST
study is the largest, most comprehensive one to date, evaluating
digital technology across four different manufacturers of digital
equipment.
Farria says that even with the
in-depth look at digital mammography, no one technology solves all
diagnostic problems. Screen-film
mammography, digital mammography, ultrasound, and even magnetic
resonance imaging are used, sometimes together, for definitive diagnoses. Washington University
supports clinical trials and critical
review of published data before

Additional studies available to high-risk women
The STAR Trial: One of the largest breast cancer prevention studies ever, the Study of
Tamoxifen and Raloxifene, or STAR trial, is recruiting volunteers at more than 500
centers across the United States, Puerto Rico and Canada. The trial will include
22,000 postmenopausal women at increased risk of breast cancer to determine
whether the osteoporosis prevention drug raloxifene (Evista®) is as effective in reducing
the chance of developing breast cancer as is tamoxifen (Nolvadex®). The Siteman
Cancer Center at Washington University and Barnes-Jewish Hospital is one of the
trial centers in St. Louis. For more information about STAR and a list of participating centers, call the National Cancer Institute's Cancer Information Service at
1 -800-422-6237 or go to http://www.nci.nih.gov/clinicaltrials/digestpage/STAR.

The Sisters Study: For sisters of women who have had breast cancer. Few breast cancer studies have focused on the potential role of the environment or on the interaction
between the environment and genes. Sisters of women with breast cancer are at
higher risk for developing breast cancer themselves. Sisters share some of the same
genes and early life exposures, which may explain their higher risk. By studying the
sisters of women with breast cancer and following them over time, researchers hope to
learn a great deal about the risk factors for breast cancer.

The 50,000 women who join in this effort will provide information about their health,
lifestyle, and environment. They will be asked to update some of that information
annually for 10 or more years. As part of the study, researchers will compare the
information (provided by sisters who develop breast cancer and by those who do not)
to identify clues to the causes of breast cancer and ways to prevent it. Women are
eligible for the Sister Study if they live in the United States, have never had breast
cancer, are 35 to 74 years old, and have a full or half sister with breast cancer, living

>»
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or deceased. For more information, go to http://www.sisterstudy.org.

breast Cancer ^Diagnosis
^[Treatment
Dione Farria, MD, in the reading roam in the Breast
Health Center on the fifth floor of the Center for
Advanced Medicine.

investing in technology that might
not improve quality of care.
Beyond that, University
researchers want to determine the
most appropriate applications for
each modality. Farria encourages
physicians to keep abreast of new
and existing clinical trials and to
refer their patients as appropriate.
"Clinical trials not only help to
ensure technology is used appropriately and cost-effectively, but
can improve quality of care and
treatment outcomes for current
patients and for other patients yet
to come."
Candidates for the DMIST trial
at the Washington University site
must meet the following criteria:
> Be present for their normal
screening mammogram at their
normal screening interval
> No symptoms of breast
pathology
Breast Ultrasound
Part of the problem with my negative mammogram may have been my very
dense breast tissue. This type of tissue can obscure lesions on mammograms. Ultrasound breast imaging is not limited by breast tissue density. Another multicenter
ACRIN trial that will get underway in early 2004 will evaluate screening breast ultrasound in high-risk women. "We are in the final stages of getting ready to accept
patients," says Farria. She and Maria Schmidt, MD, assistant professor of radiology,
who directed the breast cancer education team, will be co-principal investigators for
that study. Physicians who wish to refer patients will be given contact information
when enrollment is open. Candidates for this study are women with dense breast

> No personal history of breast
cancer
> No breast implants
> Cannot be pregnant.
Study participants will come to
Washington University Medical
Center for a regular screening
mammogram with the standard
screen-film method. They will also
have a digital mammogram. The
following year, participants will
return to the medical center for a

tissue who might be at high risk for the following reasons: having the BRCA 1 or 2
breast cancer gene, a strong family history of breast cancer, past diagnosis of breast
cancer, or a high risk lesion from a prior breast biopsy. Participants will receive
annual screening mammograms and screening ultrasound tests for three years. This
study will be limited to about 200 participants.
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"Clinical trials...can improve quality of care
and treatment outcomes for current patients
and for other patients yet to come."
regular screen-film mammogram or
provide one from another facility if
they are not able to return. Most
women will be finished at that
point. A small subgroup of women
will receive follow-up phone calls
for two to three years about subsequent mammograms and breast
health. Farria expects official
results of the study to be published
in 2005-2006.
She adds that she is pleased to
lead this study site because of her
long-time interest in women's
health and prevention. "This is a
wonderful place to be based
because our Breast Health Center
has some exceptional specialists
involved in women's care. In many
community hospitals, the radiologists are generalists. At Washington
University, we have mammography
radiology specialists. The same
applies in treatment. We have surgeons who specialize in breast
surgery. The more time a doctor
devotes to an area, the more
skills are gained and expertise
is developed."
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Farria's background includes a
Masters in Public Health, postgraduate work in preventive medicine,
and a fellowship in health services
research, in addition to her work in
radiology. Her interest does not
start and stop with diagnosis and
treatment. She is an advocate for
women's physical and fiscal health.
She was also a member of a multidisciplinary team developing communication materials on breast
cancer diagnosis and treatment for
women, including minority women
and those with little formal education. "I have a strong interest in
quality of care and making costeffective choices. Improving health
starts with prevention and how the
health care team communicates
with patients every step of the
process."
Bokern echoes her enthusiasm:
"I'm so thankful I work in such a
wonderful place, and I bless people
who do clinical trials. It makes our
lives healthier, happier and longer."
Her comments have a personal
context. As a DMIST study participant, Bokern was diagnosed with
breast cancer.
Breast cancer will become less
of a threat as women take advantage of all the resources available
to them: researching and using educational materials, becoming

The American College of Radiology Imaging Network
(ACRIN) is a National Cancer Institute-funded
cooperative group that manages clinical trials. At
the 2003 ACRIN Annual Meeting in September,
Darlene Bird, RT(M), research coordinator, received
a Certificate of Achievement Award for her role in
recruiting participants for the DMIST study. The
Washington University site now has the largest
number of participants than any of the other 34 sites.
At left is Bruce Hillman, MD, ACRIN chairman, and
Daniel Sullivan, MD, NCI associate director.

trained in breast self-examination,
having recommended exams and
screening tests on schedule, participating in clinical trials where
appropriate, and using physicians
who have strong backgrounds in
detection and treatment. Bokern
has been treated for her breast cancer and is back at work, educating
women and encouraging them to
take advantage of clinical trials. EU
Editor's Note: Patients will be enrolled in
the Digital Mammographic Imaging
Screening Trial through October 27, 2003.
If you are interested in participating,
call the Washington University Medical
Center Volunteer for Health office at
(314) 362-1000, line 6.

17

I

g Contributions.

Fred Jenner Hodges III, MD, professor of
radiology, came to medicine quite naturally,
having come from a family of physicians.
His father, Fred Jenner Hodges II, was
professor and chair of the Department of
Radiology at the University of Michigan. And
the family's ancestors include Edward Jenner,
MD, who discovered the smallpox vaccine.

I
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Above: MIR neuroradiology section: (left to right) doctors Mokhtar Gado, Hodges,
Wippold, Robert McKinstry, Katie Vo, Joshua Shimony, and DeWitte Cross. Not
shown are doctors Colin Derdeyn, Christopher Moran, and Alan Williams.
Left: Gilbert Jost, MD, director of Mallinckrodt Institute, presents a commemorative
plaque to Fred Hodges, MD, in recognition of his 32 years at the Institute.

Franz Wippold, MD, chief of
neuroradiology, presents
Hodges with a proclamation
from St. Louis Mayor Francis
Slay, marking April 23 as
Fred Jenner Hodges Day.
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Hodges first came to Mallinckrodt Institute in 1957 as an
assistant professor of radiology. That same year MIR Director
Hugh Wilson, with the assistance of
Torgny Greitz, MD, from Sweden
(where neuoradiology was developed), established the neuroradiology section. This recent and
promising addition to the field of
radiology was not available in other
United States medical centers, so
Mallinckrodt Institute quickly
became a leader in the subspecialty.
Hodges was named head of MIR's
neuroradiology program in 1958.
During his time at MIR, Hodges
received a National Institutes of
Health Fellowship in Neuroradiology
and spent one year in Gothenburg,
Sweden. He left MIR in 1966 to
become chief of neuroradiology at
Johns Hopkins Hospital in Baltimore, Maryland. He returned to
Mallinckrodt Institute in 1980 as professor of radiology and codirected
the neuroradiology section with
Mokhtar Gado, MD.
Hodges is a past president of
the American Society of Neuroradiology and a reviewer for the American Journal of Neuroradiology. In
1975, he served on the Panel of Consultants to the Commis•
sion on CIA Activities
within the United States,
reviewing the circumstances of the assassination of President John F.
Kennedy. He served for 21
years as a guest examiner
for the American Board of
Radiology.
In April 2003 Hodges retired
from Mallinckrodt Institute. After a
career that spans nearly six decades,
including 32 years of practicing diagnostic radiology at the Institute, he
plans a quiet retirement—maybe puttering around his Webster Groves
garden and some travelling. EH3
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In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
Department of Radiology or Department of Radiation
Oncology are highlighted in boldface type.

JOINT
APPOINTMENT

FIRST-YEAR
FELLOWS

Joel Perlmutter, MD,
professor of neurology, of
neurological surgery, and of
radiology, was appointed
professor of physical therapy
at Washington University in
St. Louis.

Scott Andersen, MD, neuroradiology clinical fellow,
received an undergraduate
degree and a medical degree
from Duke University. He
completed a one-year internship at St. Johns Mercy Medical Center and a diagnostic
radiology residency (chief
resident, 2002-2003) at
Mallinckrodt Institute of
Radiology.

NEW FACULTY
Jennifer Gould, MD,
instructor in radiology, Division of Diagnostic Radiology,
Department of Radiology.
Wen Li, PhD, research
instructor in radiology, Division of Radiological Sciences,
Department of Radiology.
Francisco Rodriguez, MD,
instructor in radiology, Division of Diagnostic Radiology,
Department of Radiology.
Xiankai Sun, PhD, research
instructor in radiology, Division of Radiological Sciences,
Department of Radiology.

Joelle Biernacki, MD,
magnetic resonance imaging
clinical fellow, received an
undergraduate degree and a
medical degree from the
University of Missouri,
Kansas City. She completed
an internship at the University
of New Mexico.
Tedric Boyse, MD, musculoskeletal radiology clinical
fellow, received an undergraduate degree from Duke
University and a medical
degree from Vanderbilt University. He completed an
internship at St. Mary's
Medical Center, San Francisco, and a residency at the
University of Michigan.
Fadi El-Merhi, MD,
musculoskeletal radiology
clinical fellow, received an
undergraduate degree and a
medical degree from the
American University of
Beirut. He completed an
internship at The Good
Samaritan Hospital and a
residency at Yale-New Haven
Bridgeport Hospital.
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Aamer Farooki, MD, magnetic resonance imaging clinical fellow, received an
undergraduate degree from
Harvard University and a
medical degree from Duke
University. He completed an
internship at St. Barnabas
Medical Center and a diagnostic radiology residency
at Mallinckrodt Institute of
Radiology.
Craig Glaiberman, MD,
interventional radiology clinical fellow, received an undergraduate degree from the
University of California and a
medical degree from the University of Texas Health Sciences Center. He completed
an internship and a residency
at the Milton S. Hershey
Medical Center.
Brett Gratz, MD, abdominal
radiology clinical fellow,
received an undergraduate
degree and a medical degree
from Duke University. He
completed an internship at
Carilion Memorial Hospital
and a diagnostic radiology
residency at Mallinckrodt
Institute of Radiology.
Peter Hu, MD, interventional radiology clinical
fellow, received an undergraduate degree from
Brigham Young University
and a medical degree from
the University of Utah. He
completed an internship at
MeritCare Hospital and a residency at the Medical College
of Wisconsin.

Cylen Javidan-Nejad, MD,
chest radiology clinical fellow, received a medical
degree from the Iran School
of Medical Sciences. She
completed an internship and
a residency at Henry Ford
Hospital.
James Joseph, MD, magnetic resonance imaging
clinical fellow, received an
undergraduate degree from
the University of Richmond
and a medical degree from
Ohio State University. He
completed an internship at
Riverside Methodist Hospital
and a residency at the University of Texas Southwestern.
Robert Kadner, MD, neuro
radiology clinical fellow,
received an undergraduate
degree from the University of
Virginia and a medical degree
from Georgetown University.
He completed an internship at
Georgetown University and
a diagnostic radiology residency (chief resident, 20022003) at Mallinckrodt
Institute of Radiology.
Aneel Mandava, MD, inter
ventional radiology clinical
fellow, received an undergraduate degree from Johns
Hopkins University and a
medical degree from the
University of Maryland. He
completed an internship at
the University of Maryland
Medical System and a residency at the Long Island
Jewish Medical Center.
Avi Mazumdar, MD, neuro
radiology clinical fellow,
received an undergraduate
degree from Johns Hopkins
University and a medical
degree from New York University. He completed an
internship at the University
of California, San Diego,
and a diagnostic radiology
residency at Mallinckrodt
Institute of Radiology.
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5avid Mueller, MD, musculoskeletal radiology clinical
fellow, received an undergraduate degree and a Masters of Science degree from
(Washington University in
ft. Louis, and a medical
tlegree from the University of
lissouri, Columbia. He completed an internship at
J3t. Johns Mercy Medical Cener and a diagnostic radiology
Residency at Mallinckrodt
stitute of Radiology.
idres O'Brien-Solar, MD,
abdominal radiology clinical
[fellow, received an underraduate degree and a medical degree from the Catholic
Jniversity of Chile. He comIpleted an internship and a
residency at the Catholic
Jniversity of Chile.
Jason Oliphant, MD, musculoskeletal radiology clinical
[fellow, received an undergraduate degree and a medJical degree from Yale
Jniversity. He completed
| an internship at Hospital of
It. Raphael and a diagnostic
radiology residency at
Mallinckrodt Institute of
[Radiology.
Mmitrios Papadouris, MD,
interventional radiology clinical fellow, received an undergraduate degree from the
University of Toronto and a
[ medical degree from the University of Western Ontario.
He completed an internship at
; Victoria General Hospital and
a residency at the University
of British Columbia.
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Naveen Parti, MD, neuroradiology clinical fellow,
received an undergraduate
degree from Vanderbilt University and a medical degree
from Emory University. He
completed an internship at
St. Vincent's Hospital and a
diagnostic radiology residency (chief resident, 20022003) at Mallinckrodt
Institute of Radiology.

Cary Shlimovitz, MD, neuroradiology clinical fellow,
received an undergraduate
degree from the University of
Texas, Austin, and a medical
degree from Washington
University in St. Louis. He
completed an internship at
Barnes-Jewish Hospital and
a diagnostic radiology residency at Mallinckrodt
Institute of Radiology.

Srinivasa Prasad, MD,
abdominal radiology clinical
fellow, received a medical
degree from Bangalore Medical College. He completed
radiology training at King
Edward Memorial Hospital
and a radiology research
fellowship at Massachusetts
General Hospital.

Megan Strother, MD, neuroradiology clinical fellow,
received an undergraduate
degree from Princeton
University and a medical
degree from the University of
Arkansas. She completed an
internship and a residency at
Wake Forest University.

Allan Reier, MD, interventional radiology clinical
fellow, received an undergraduate degree from the
University of Miami and a
medical degree from Jefferson Medical College. He completed an internship at
Riverside Methodist Hospital
and a residency at Ohio State
University.
Dennis Rivet, MD, neuroradiology clinical fellow,
received an undergraduate
degree from the U.S. Naval
Academy and a medical
degree from Dartmouth University. He completed an
internship and a residency at
BarnesJewish Hospital.
Wael Saad, MD, interventional radiology clinical fellow, received a medical
degree from Am Shams University, Faculty of Medicine.
He completed an internship at
Union Memorial Hospital and
a residency at the University
of Rochester.

Lisa Wang, MD, abdominal
radiology fellow, received an
undergraduate degree from
the Georgia Institute of Technology and a medical degree
from the Medical College of
Georgia She completed an
internship at the University
of Virginia and a residency at
Saint Louis University.

FIRST-YEAR
DIAGNOSTIC
RADIOLOGY
RESIDENTS
John Anderson, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from Case
Western Reserve University.
He completed an internship at
Brooke Army Medical Center.

George Cannon, MD, assistant in radiology, received an
undergraduate degree from
Brigham Young University
and a medical degree from
the University of Utah. He
completed an internship at
Intermountain Health Care's
LSD Hospital.
Jeffrey Carenza, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from Texas
A&M University. He completed an internship at Austin
Medical Center.
Kristopher Cummings, MD,
assistant in radiology,
received an undergraduate
degree and a medical degree
from the University of
Alabama. He completed an
internship at BarnesJewish
Hospital.
Gregory dePrisco, MD,
assistant in radiology,
received an undergraduate
degree from Texas A&M University and a medical degree
from the University of Texas
Southwestern. He completed
an internship at Baylor University Medical Center.
Joseph Erinjeri, MD, assistant in radiology, received an
undergraduate degree from
the University of Michigan
and a medical degree from
Washington University in
St. Louis. He completed an
internship at Virginia Mason
Hospital.
Phoebe Freer, MD, assistant
in radiology, received an
undergraduate degree from
Amherst College and a medical degree from Washington
University in St. Louis. She
completed an internship at
HealthOne Alliance.
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FIRST-YEAR DIAGNOSTIC
RADIOLOGY RESIDENTS
Continued from page 21
Heather Garrett, MD, assistant in radiology, received an
undergraduate degree from
the University of Virginia and
a medical degree from Washington University in St. Louis.
She completed an internship
at Saint Louis University
Hospital.

Shao Pow Lin, MD, assistant
in radiology, received an
undergraduate degree from
Stanford University and a
medical degree from Washington University in St. Louis.
He completed an internship
at St. John's Mercy Medical
Center.

William Holloway, MD,
assistant in radiology,
received an undergraduate
degree from the University of
South Carolina and a medical
degree from the University of
Chicago Pritzker School of
Medicine. He completed an
internship at Louis Weiss/
University of Chicago.

John Loh, MD, assistant in
radiology, received an undergraduate degree from the
University of Michigan and a
medical degree from Washington University in St. Louis.
He completed three years of
orthopedic training at the
University of Pittsburgh.

Jack Jennings, MD, assistant in radiology, received an
undergraduate degree from
Wheaton College and a medical degree from the University of South Florida. He
completed an internship
at the University of South
Florida Health Sciences
Center.
Neil Kennedy, MD, assistant
in radiology, received an
undergraduate degree and a
medical degree from the
University of Wisconsin. He
completed an internship at
St. Luke's Medical Center.
Michelle Lee, MD, assistant
in radiology, received undergraduate degrees from Saint
Louis University, Washington
University in St. Louis, and
Southern Illinois University
at Edwardsville, and a medical degree from Northwestern University. She completed
an internship at MetroHealth
Medical Center.

Shawyon Shadman, MD,
assistant in radiology,
received an undergraduate
degree from Duke University
and a medical degree from
Washington University in
St. Louis. He completed two
years of orthopedic training at
the University of Rochester.
Michael Smith, MD, assistant in radiology, received an
undergraduate degree from
the University of Utah and a
medical degree from Washington University in St. Louis.
He completed an internship at
Carilion Health System of
Virginia.

NUCLEAR
MEDICINE
RESIDENTS
Randal Anderson, MD,
assistant in radiology,
received an undergraduate
degree from Brigham Young
University and a medical
degree from the University of
Iowa. He completed an internship and a residency at the
University of Iowa Hospitals
and Clinics.
Dennis Hsueh, MD, assistant in radiology, received an
undergraduate degree from
the University of California,
Berkeley, and a medical
degree from the University of
Texas, San Antonio. He completed an internship at Loma
Linda University Medical
Center and a residency at
the State University of New
York, Syracuse.
Akash Sharma, MD, assistant in radiology, received an
undergraduate degree from
the University of Delaware
and a medical degree from
Ross University School of
Medicine. He completed an
internship at Prince George's
Hospital Center and a residency at Hartford Hospital.

Feiyu Xue, MD, PhD, assis
tant in radiology, received an
undergraduate degree from
Beying University, a Masters
of Science degree from
Tulane University, a medical
degree from Dartmouth University, and a doctoral degree
from Yale University. He completed a one-year internship
at May Imogene Bassett Hospital and a diagnostic radiology residency at Mallinckrodt
Institute of Radiology.
Jane Yang, MD, assistant in
radiology, received a medical
degree from Capital University of Medical Sciences. She
completed a pediatric radiology fellowship at Long Island
Jewish Medical Center, a
diagnostic radiology residency at Beying Ji Shui Tan
Hospital, and a surgical residency at Beying Yan Shan
Petrochemical General
Corporate Hospital.

FIRST-YEAR
RADIATION
ONCOLOGY
RESIDENT
Andrew Hope, MD, assistant
in radiation oncology,
received a medical degree
from the University of
Wisconsin, Madison. He
completed an internship at
Aurora Health Care-St. Luke's
Medical Center.

George Wang, MD, assistant
in radiology, received an
undergraduate degree from
Rice University and a medical
degree from Duke University.
He completed an internship at
Presbyterian Hospital of
Texas.
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.RANTS
amuel Achilefu, PhD,
;sociate professor of radioligy, as principal investigator, received a $153,000
;rant from the National Instiites of Health to study
Novel monomolecular multi
lodality imaging agents."
loinvestigators for the oneear study are Michael
r
elch, PhD, professor of
iadiology; Barry Siegel,
MD, professor of radiology;
MGregory Lanza, MD, and
jSamuel Wickline, MD,
■Department of Medicine; and
Brinton Chance, MD, University of Pennsylvania.
Mark Conradi, PhD, professor of physics and of
radiology, as principal investigator, received a $150,000
Irrant from, the Global Envionmental Management
initiative (GEMI) Foundation
or research on "Lung imaging with C2F6 gas by F-19
[klR." Coinvestigators for the
r
o-year grant are Jie
Iheng, PhD, assistant professor of radiology, and
•mitriy Yablonskiy, PhD,
»Sc, professor of radiology
id of physics.
] 1

Jregg Franklin, MD, PhD,
ssistant in radiation oncolDgy, received the Siemens
ledical Solutions/ Radiological Society of North America (RSNA) Research
Resident Grant for "A pilot
study on functional and
physiologic imaging of the
salivary glands by magnetic
resonance imaging on
patients treated by intensity
nodulated radiation therapy
for head and neck cancers."
Coinvestigators for the

$30,0000 grant are Joseph
Deasy, PhD, associate
professor of radiation
oncology, and Thomas
Conturo, MD, PhD, associate professor of radiology.
Robert Gropler, MD,
associate professor of
radiology, of medicine,
and of biomedical engineering, as principal investigator, received a $3.7
million grant from the
National Heart, Lung, and
Blood Institute of the
National Institutes of
Health for "Altered
myocardial fatty acid
metabolism in obesity."
Coinvestigators for the
five-year grant are Pilar
Herrero, MS, research scientist of radiology; and
Samuel Klein, MD, and Linda
Peterson, MD, Department
of Medicine
Daniel Low, PhD, associate
professor of radiation oncology, received a three-year
grant from the National
Institutes of Health for "Lung
trajectory mapping." Coinvestigators for the $1.1
million grant are Joseph
Deasy, PhD, associate
professor of radiation oncology; David Politte, DSc,
research instructor in radiology; Bruce Whiting, PhD,
research assistant professor
of radiology; and Gary Christensen, PhD, University of
Iowa.
Robert Mach, PhD, professor of radiology, received a
one-year grant of $272,942
from the National Institute
on Drug Abuse for research
on "Development of D3
antagonists to treat cocaine
addiction."

2002-2003 Radiation
Oncology Residents
(Front row, left to right) Doctors Lilie Lin, Parag
Parikh, Binh Tran, Gregg Franklin, Fengming Kong,
Catherine Wu. (Back row) Doctors Angel Blanco,
Anurag Singh, Wayne Lamoreaux, Andrew Hope,
Jon Anders, Charles Hechtman.

Robert McKinstry, MD,
PhD, assistant professor of
radiology; Asif Moinuddin,
MD, research associate; and
Kathy Grange, PhD, Department of Pediatrics and
Genetics, are coinvestigators
for a five-year grant to study
"Prefrontally-mediated memory in phenylketonuria."
Principal investigator for the
$1.2 million grant is Desiree
White, PhD, Department of
Psychology. The study is
in collaboration with Oregeon Health and Sciences
University.
Tom Miller, MD, PhD, professor of radiology, as principal investigator, received a
$1.7 million grant from the
National Institutes of Health,
National Cancer Institute, for
research on "Positron emis-

sion tomography in prostate
cancer." Coinvestigators for
the five-year grant are Farrokh Dehdashti, MD, associate professor of radiology;
Barry Siegel, MD, professor of radiology; Cary
Siegel, MD, assistant professor of radiology; Michael
Welch, PhD, professor of
radiology; Adam Kibel, MD,
and Gerald Andriole, MD,
Department of Urology; Jeff
Michalski, MD, associate
professor of radiation oncology; Kathryn Trinkaus, Biostatistics; Peter Humphrey,
MD, Department of Pathology and Immunology; and
Nobuyuki Oyama, PhD,
Fukui Medical University,
Japan.
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GRANTS
Continued from page 23
Steven Peterson, PhD,
professor of neurology, of
neurological surgery, of
anatomy and neurobiology,
and of radiology, as principal
investigator, received a $1
million grant from the
National Institutes of Health
for "The study of task-level
control signals using fMRI."
Coinvestigators for the grant
are Randy Buckner, PhD,
associate professor of psychology; Larry Jacoby, PhD,
Department of Psychology;
and Bradley Schlaggar,
MD, PhD, assistant professor of neurology, of pediatrics, and of radiology.
William Powers, MD, professor of neurology, of neurological surgery, and of
radiology, as principal investigator, received a $5.2 million program project grant
from the National Institute of
Neurological Disorders to
study "Clinical pathophysiology of acute brain injury."
Coinvestigators are Allyson
Zazulia, MD; Venkatesh Aiyagari, MD; and Michael
Diringer, MD, of the Department of Neurology; Tom
Videen, PhD, research professor of neurology, of neurological surgery, and of
radiology; Colin Derdeyn,
MD, associate professor of
radiology; and Carmen
Dence, MS, research scientist of radiology.
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APPOINTMENTS/
ELECTIONS
Kyongtae Bae, MD, PhD,
assistant professor of radiology, was elected to an indefinite term as a member of the
Radiological Society of
North America's Education
Grant Study Section and
the Research Grant Study
Section.
Colin Derdeyn, MD, associate professor of radiology,
was appointed as a consultant
to the Neurological Devices
Panel of the Medical Devices
Advisory Committee for the
Center for Devices and Radiological Health of the Food and
Drug Administration.
Daniel Low, PhD, associate
professor of radiation oncology, was appointed to a oneyear term as vice president,
facility, for the Hillel Center
at Washington University in
St. Louis.
Elizabeth McFarland, MD,
associate professor of radiology, was elected to the Association of University
Radiologists' 2003-2004 Board
of Directors as the director of
the Philips-AUR Faculty
Development Program. She
was appointed director for
Mallinckrodt Institute's Summer Research Program.
Robert McKinstry, MD,
PhD, assistant professor of
radiology, was appointed to a
one-year term on the Neuroradiology/Head & Neck Subcommittee of the Scientific
Program of the Radiological
Society of North America

Joel Perlmutter, MD, professor of neurology, of neurological surgery, and of
radiology, was elected to a
two-year term as a member of
the Parkinson Study Group
Executive Committee. He was
appointed to a three-year
term on the Standards Committee of the Huntington's
Study Group.
Steven Peterson, PhD, professor of neurology, of neurological surgery, of anatomy
and neurobiology, and of radiology, was appointed the
James S. McDonnell Professor of Cognitive Neuroscience
at Washington University in
St. Louis.
Joseph Roti Roti, PhD, professor of radiation oncology,
was appointed co-chair of the
Bioelectromagnetic Society
25th Annual Meeting held in
Maui, Hawaii, on June 22-27.
He was appointed as a member of the National Research
Service Award Study Section
held in Washington, DC, on
July 17 and 18.
Anurag Singh, MD, assistant
in radiation oncology, was
elected vice-chairman of the
Association of Residents in
Radiation Oncology. He was
appointed as resident liaison
to the Education Committee
and the Refresher Course
Committee of the American
Society for Therapeutic Radiology and Oncology. Singh
was appointed to the Executive Board of the Association
of Directors of Radiation
Oncology Programs and as a
member of the Education of
Physicians Subcommittee of
the American Association of
Physicists in Medicine.

HONORS/
AWARDS
Kyongtae Bae, MD, PhD,
assistant professor of radiology, received a Cum Laude
Award from the Society of
Computed Body Tomography
and Magnetic Resonance for
each of two presentations
("Principles and practices of
contrast material delivery for
MDCT" and "CT coronary
artery imaging") made at the
26th Annual Course Meeting in
April, 2003.
Christine Menias, MD,
assistant professor of radiology, received a visiting professorship at the Universidad
Catolica in Santiago, Chile.
Bradley Schlaggar, MD,
PhD, assistant professor of
neurology, of pediatrics, and
of radiology, received the
2003 Young Investigator
Award, in the amount of
$20,000, from the Child
Neurology Society for his
research on "Development of
controlled visual lexical processing; fMRI studies."
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SCTURES/
RESENTATIONS
\ /ongtae Bae, MD, PhD,
i sistant professor of radiolbgy, presented "Principle and
tractice of computer-aided
liagnosis" to the Department
k Nuclear Engineering,
I orean Advanced Institute of
I echnology and "CT coronary
tery imaging" to the Departnent of Radiology, Chungvfam University, DaeJeon,
■forea, June 4. He spoke on
"Computer-aided diagnosis in
liology" at Seoul National
Jniversity, Department of
^Computer Science, Seoul,
Korea, June 5. He presented
"Computer-aided diagnosis in
chest radiology" at the International Symposium on
ssues in Thoracic Radiology:
Jpdate, Seoul, Korea, June 7
rid 8. Bae spoke on "Principles and applications of
)CT" at Hyun-Dai Joong-

ang Hospital, Asan University,
Seoul, Korea, on June 10, and
at Yeong-Dong Severance
Hospital, Seoul, Korea, June
13. He presented "MDCT
made easy" to the Department of Radiology, Sam-Sung
Hospital, Seonggkyunkwan
University, Seoul, Korea, June
10. He spoke on "Radiology
research in the USA update,"
"Basic body MR physics," and
"CT coronary artery imaging"
at the Department of Radiology, Seoul National University, Seoul, Korea, June 11-13.
Bae presented "Principles and
practice of contrast material
delivery for MDCT" at the 5*
Annual International Symposium on Multidetector-Row
CT, San Francisco, California,
June 25-28. He presented
"MDCT" to the Department of
Radiology, University of
Kansas Medical Center,
Kansas City, Kansas, July 15.
He spoke on "Technical
aspects of contrast in CTA

Purdy Lecture
John Wong, PhD, director of
clinical physics for the Department of Radiation Oncology at
William Beaumont Hospital in
Royal Oak, Michigan, presented
The First James A. Purdy Medical Physics Lecture on May 16.
He spoke on "Image guided radiation therapy: present methods
and future challenges." Shown
(left to right) are James Purdy,
PhD, professor of radiation
oncology and chief of the Division of Physics; John Wong,
PhD; and Carlos Perez, MD, professor of radiation oncology and
chair of the Department of Radiation Oncology.
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imaging" at the Applied Radiology Focus Group for CTA
Contrast Administration, New
York City, New York, July 25.
Jeffrey Bradley, MD, assistant professor of radiation
oncology, as invited lecturer,
presented "PET targeting in
radiation therapy: applications in lung and head and
neck cancer" at the Case
Western Reserve University
PET Symposium, Cleveland,
Ohio, May 15 and 16. He presented "PET/CT for radiation
therapy planning: the concepts of biological target volumes" at the CPS Innovations
Advisory Board Meeting, New
Orleans, Louisiana, June 20.
Colin Derdeyn, MD, associate professor of radiology,
spoke on "Treatment of
carotid atherosclerotic disease: medicine, surgery, or
stent" at Grand Rounds,
Salem Public Hospital, Salem,
Illinois, April 8, and at the 3rd

Annual Neuroscience Update,
Carbondale Memorial Hospital, Carbondale, Illinois, July
12. He presented "Cerebral
hemodynamics in acute and
chronic ischemia" and
"Preparing a grant application" at the 41st Annual Meeting of the American Society of
Neuroradiology, Washington,
DC, April 29.
Louis Gilula, MD, professor
of radiology and of surgery,
presented "Lumbar diskography," "Introduction to vertebroplasty," and "Lumbar and
sacral nerve blocks" at Skeletal Radiology 2003, Scottsdale, Arizona, April 6-9. He
spoke on "Cervical spine
trauma" and "Plain film
approach to bone tumors" at
Oregon Health and Science
University, Portland, Oregon,
June 17.
Perry Grigsby, MD, professor of radiation oncology and
of radiology, presented
"Positron emission tomography (in gynecologic cancer)"
at the Annual Gynecologic
Cancer Conference, St. Louis,
Missouri, April 25. He spoke
on "Chemoradiation for cervical cancer—who not to treat"
and "Clinical applications of
HDR brachytherapy" at the
9th Annual Conference of the
Florida Society of Gynecologic Oncologists, Long Boat
Key, Florida, June 6. He presented "Controversies in cervical and endometrial cancer"
at the Semi-Annual Gynecologic Oncology Group Meeting & Symposium, Reno
Nevada, July 24-27.
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LECTURES/PRESENTATIONS
Continued from page 25
Jay Heiken, MD, professor
of radiology, spoke on "Pancreatic cancer: evaluation
with multidetector CT," "CT
evaluation of small bowel
obstruction," and "CT
colonography: What are the
issues?" at the 33"1 Meeting of
the Sao Paulo Radiological
Society, Sao Paulo, Brazil,
May 14. As a representative
of the Society of Computed
Body Tomography and Magnetic Resonance, he presented "Ultrasound
practitioners" at the
American College of Radiology Intersociety Summer
Conference, Pasadena,
California, August 1-3.
Saulo Klahr, MD, professor
of medicine and of radiology,
presented "Obstructive
nephropathy and renal fibrosis" at the Management of
Comorbidities in Kidney Disease Conference, Long Island
College Hospital, New
York City, New York, May 30
and 31.
Jason Lewis, PhD, research
instructor in radiology, presented "Cu-ATSM-PET imaging of hypoxia basic science
to the clinic" at Memorial
Sloan-Kettering Cancer Center, New York City, New
York, June 16.

Elizabeth McFarland, MD,
associate professor of radiology, as chair of the PhilipsAUR Faculty Development
Program, spoke on "What do
we value in academics?" at
the 51s1 Annual Meeting of the
Association of University
Radiologists, Miami, Florida,
April 9-13. She presented "CT
colonography: Is it ready for
prime time?" at the Digestive
Disease Week, Combined
Clinical Symposium of Virtual
Imaging of the Colon, sponsored by the American
Society of Gastroenterology,
Orlando, Florida, May 19. She
presented "CT colonography:
performance to politics" at
the GI Division Rounds,
Department of Gastroenterology, Washington University in
St. Louis, Missouri, June 10.
Robert McKinstry, MD,
PhD, assistant professor of
radiology, spoke on "MRI of
disorders of brain development" at the 79th Annual
Meeting of the American
Association of Neuropathologists, Special Course: Magnetic Resonance Imaging of
Neurological Disease,
Orlando, Florida, June 19.
Carlos Perez, MD, professor
of radiation oncology, presented "Brachytherapy in
carcinoma of the breast,"
"Brachytherapy in carcinoma
of the uterine cervix," "3DCRT in localized carcinoma of
the prostate," "Radiation therapy accidents and quality

assurance," and "Radiation
therapy and hormonal therapy in prostate cancer" at the
II Jornadas de Radioterapia
de Alta Complkejidad Braquiterapia y Fiscia Medica, Cordoba, Argentina, July
31-August2. He spoke on
"Innovative management of
bone metastases" at the Center for Cancer Care and
Research, Lakeland, Florida,
August 15.
Joel Perlmutter, MD, professor of neurology, of neurological surgery, and of
radiology, spoke on "10minute neurological exam"
and "What's shaking in
Parkinson disease?" at the
Missouri Academy of Family
Practice, Osage Beach, Missouri, June 19. He presented
"PET imaging of movement
disorders" at the Society of
Nuclear Medicine Workshop:
Modern Imaging Technology,
New Orleans, Louisiana, June
20. Perlmutter spoke on
"PET investigations of blepharospasm" at the International Conference of Benign
Essential Blepharospasm
Foundation, Philadelphia,
Pennsylvania, August 23.
Steven Peterson, PhD, professor of neurology, of neurological surgery, of anatomy
and neurobiology, and of
radiology, presented "Strategies for studying cognitive
development with fMRI" at
the RIKEN Brain Science
Institute, Saitama, Japan,
August 9.

William Powers, MD, professor of neurology, of neurological surgery, and of
radiology, presented "Cerebrovascular disease" at the
Capri PET Conference, Capri,
Italy, May 8. He spoke on
"Logistics and pitfalls of multicenter studies with imaging"
at the National institute of
Neurological Disorders Symposium on the Role of Neuroimaging in Parkinson
Disease, Washington, DC,
July 10.
Joseph Roti Roti, PhD, professor of radiation oncology,
as platform speaker, presented "Exposure of C3H
10T1/2 ceUs to CDMA, FDMA
or TDMA radiofrequencies
does not significantly modify
gene expression" at the Electromed 2003 Symposium, San
Antonio, Texas, June 11-13.
He presented "Results of
recent studies to determine if
RF radiation can induce RNA
damage" at the 2003 Michaelson Conference, West Yellowstone, Montana, August 8-12.
Stuart Sagel, MD, professor
of radiology, spoke on "CT
angiography for pulmonary
embolism," "Role of CT in
bronchogenic carcinoma,"
"CT of the thoracic aorta,"
"CT of nonvascular mediastinal masses," and "Problematic 'unknown' CT cases" at
the Rocky Mountain Radiologic Society Meeting, Vail,
Colorado, July 11-13. He pre
sented "CT angiography for
pulmonary embolism: altern
tive/additional diagnoses,"
"CT of the pericardium," anci
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T of nonvascular mediasti1 masses" at the Thirteenth
immer Practicum of the
.; >ciety of Computed Body
' omography and Magnetic
esonance, Asheville, North
Carolina, July 27-31.
.radley Schlaggar, MD,
hD, assistant professor of
aeurology, of pediatrics, and
|f radiology, presented "An
/IRI strategy for the study of
cognitive development,
lessons from a developmental
udy of controlled lexical
processing" at the Society for
Research in Child Development, Tampa, Florida, April
I 24. He spoke on "Functional
MRI and cognitive development" at the Department of
Neurology Grand Rounds,
Jniversity of Rochester,
Rochester, New York, May 29.
Schlaggar presented "A strategy for the direct comparison
of children and adults in
developmental fMRI studies"
at the Organization for
luman Brain Mapping Methods Workshop Symposium,
'Jew York City, New York,
June 19. He presented "Studyng the developmental neurobiology of reading using
IRI" at the John Merck
Scholars Fund Summer
stitute on the Biology of
developmental Disabilities,
aceton University, Princeon, New Jersey, July 23.
J

lenry Royal, MD, professor
of radiology, presented "The
SNM: here today—where is it
going tomorrow?" and "Radiation and terrorism: perceptions and realities" at the 481"
nual Meeting, Southwestern Chapter of the Society of
Nuclear Medicine, Oklahoma
3ity, Oklahoma, April 11-13.
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Barry Siegel, MD, professor
of radiology and of medicine,
spoke on "FDG-PET: artifacts,
variants and benign lesions
simulating cancer" and "Evaluating tumor response to
treatment with PET: FDG and
beyond" at the 48th Annual
Meeting, Southwestern Chapter of the Society of Nuclear
Medicine, Oklahoma City,
Oklahoma, April 11-13. He
presented "PET artifacts/variants" and "PET in women's
imaging" at Clinical Nuclear
Medicine 2003, sponsored by
Harvard Medical School,
Boston, Massachusetts, May
13-16. As guest speaker,
Siegel presented "Assessing
response of cancer therapy
with PET: FDG and beyond"
at the Ninth Annual William
D. Kaplan Lecture, sponsored
by The Joint Program in
Nuclear Medicine and Harvard Medical School, Boston,
Massachusetts, May 13. He
presented "Interpreting PET
images" and "PET in oncology: breast and gynecological
cancers" at PET Imaging for
the Radiologist, sponsored by
the American College of Radiology, Hilton Head, South
Carolina, June 14 and 15. As
invited lecturer, Siegel spoke
on "Current status of PET in
clinical practice," "PET in
thoracic oncology," "PET in
women's cancers," and "PET
for assessing response to
therapy: FDG and beyond"
at the South African Radiological Congress 2003,
sponsored by the Radiology
Society of South Africa,
Pretoria, South Africa,
August 15-17. He also spoke
at Tygerburg Hospital,
Stellenbosch Medical
School, Cape Town, South
Africa, August 26.

Marilyn Siegel, MD, professor of radiology and of pediatrics, presented "CT of
pediatric thoracic vascular
lesions" and "Pediatric CT:
nonvascular chest applications" at the Davos Chest
Imaging Symposium, Davos,
Switzerland, April 1-4. She
spoke on "Ultrasonography of
the jaundiced child" at the
American Institute of Ultrasound in Medicine Annual
Meeting, Montreal, Canada,
May 3Uune 2. As guest lecturer, Siegel presented "Pediatric multidetector row CT" at
the Stanford University
Annual International Symposium on Multidector-Row CT,
San Francisco, California,
June 25-28. She presented
"Multidetector CT in children:
techniques and applications"
and "CT/MRI of pediatric
abdominal masses" at the
Thirteenth Summer
Practicum of the Society of
Computed Body Tomography
and Magnetic Resonance,
Asheville, North Carolina,
July 27-31.
Anurag Singh, MD, assistant
in radiation oncology, presented "FDG-PET lymph node
staging: implications for the
treatment of cervical carcinoma" to the Department of
Radiation Oncology, University of Maryland, Baltimore,
Maryland, July 1.

SYMPOSIA
In this section of FYI, only
those faculty and staff who
have Department of Radiology or Department of Radiation Oncology appointments
are listed.

AMERICAN ROENTGEN
RAY SOCIETY
103" Annual Meeting
San Diego, California
May 4-9, 2003
SCREENING FOR DISEASE WITH
CT FORUM
Elizabeth McFarland, MD,
"Colon cancer screening:
interpretation and results."
CATEGORICAL COURSE
Barry Siegel, MD, "PET for
monitoring and predicting
response to therapy."
SCIENTIFIC PRESENTATIONS
Edward Lee, MD, MPH;
Marilyn Siegel, MD;
Charles Hildebolt, DDS,
PhD; Sanjeev Bhalla, MD;
Fernando Gutierrez, MD,
"Comparison of multislice
axial, multiplanar, and 3D
volume rendering images in
evaluation of congenital thoracic aortic anomalies."
Christine Menias, MD,
"CT of nontraumatic acute
abdominal pain."
Srinivasa Prasad, MD,
"Primary hepatic lymphoma"
Marilyn Siegel, MD,
"Neonatal cranial
sonography."
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SYMPOSIA
Continued from page 27
POSTER PRESENTATIONS
Edward Lee, MD, MPH;
Christine Menias, MD;
Amy Hara, MD; Jay
Heiken, MD; Dennis Balfe,
MD, "Practical multiplanar
CT evaluation of small bowel
obstruction: techniques and
clinical applications." Certificate of Merit Award.
Edward Lee, MD, MPH;
Markus Lammle, MD;
Kianoush Rezaei, MD;
Vamsidhar Narra, MD; Jeffrey Brown, MD, "Practical
MRI of the liver: principles,
applications, and protocol—
a review for the general
radiologist."
Srinivasa Prasad, MD;
Christine Menias, MD;
Vamsidhar Narra, MD;
Cary Siegel, MD; William
Middleton, MD; Sharlene
Teefey, MD, "Multimodality
imaging of the female urethra:
indications, techniques, and
spectrum" Certificate of
Merit Award.
Srinivasa Prasad, MD, "CT
evaluation of acute gynecologic conditions."
Srinivasa Prasad, MD;
Humberto Rosas, MD;
Christine Menias, MD;
Vamsidhar Narra, MD; Jay
Heiken, MD, "Fat-containing
liver lesions: radiologic-pathologic correlation." Certificate
of Merit Award.
Kianoush Rezaei, MD;
Markus Lammle, MD; Vamsidhar Narra, MD; Robert
McKinstry, MD, PhD; Jef-

is

frey Brown, MD, "Practical
MRI of the fetus: principles
and applications." Certificate
of Merit Award.

THE SOCIETY FOR
PEDIATRIC RADIOLOGY
46"' Annual Meeting
San Francisco, California
May 7-10, 2003
WORKSHOPS
Marilyn Siegel, MD, "Multiinstitutional pediatric cancer
imaging trials: an update";
"Effective screening principles: applications in pediatric
radiology."

MIR in South Africa
As a Radiological Society of North America (RSNA)
International Visiting Professor, Marilyn Siegel, MD,
professor of radiology and of pediatrics, presented "CT
of common focal hepatic masses," "CT of pediatric
mediastinal masses," "Pediatric renal masses: multimodality imaging," "Imaging acute abdominal pain in
children," and "Pediatric pelvic masses: CT and MRI"
at the South African Radiological Congress 2003,
sponsored by the Radiology Society of South Africa,
Pretoria, South Africa, August 15-17. While in South
Africa, she also presented invited lectures at Pretoria
Academic Hospital, Johannesburg Hospital, Red Cross
Hospital, and Ga Rankua Hospital, August 18 and 19.
The RSNA International Visiting Professor team: (left to right): Doctors Scott
Pretorius, University of Pennsylvania; Marilyn Siegel; Anina Wilkes, Thomas
Jefferson Unviersity.

SCIENTIFIC SESSIONS
Edward Lee, MD, MPH;
Marilyn Siegel, MD; Fernando Gutierrez, MD; Sanjeev Bhalla, MD; Charles
Hildebolt, DDS, PhD, "Comparison of multislice axial,
multiplanar and 3D volume
rendering images in evaluation of tracheobronchial
stenosis in children with thoracic vascular anomalies."
Edward Lee, MD, MPH;
Marilyn Siegel, MD;
Charles Hildebolt, DDS,
PhD, "Abdominal post-transplant lymphoproliferative
disorder in pediatric lung
transplant recipients: an
unrecognized problem."
POSTER SESSIONS
Edward Lee, MD, MPH;
Marilyn Siegel, MD; Fernando Gutierrez, MD; Sanjeev Bhalla, MD; Charles
Hildebolt, DDS, PhD, "Pediatric congenital mediastinal
and pulmonary vascular
anomalies: a pictorial review
with emphasis on multidetector CT and 3D appearance of
vascular anomalies."
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SOCIETY OF NUCLEAR
If EDICINE
fff" Annual Meeting
New Orleans, Louisiana
Vune 21-25, 2003
| Carolyn Anderson, PhD,
comoderator, Radiopharmaceutical Chemistry Track
view Chemistry—Oncology II.
7

arrokh Dehdashti, MD,
noderator, Oncology/Hemaalogy Track Oncology—
Clinical Diagnosis: Melanoma
ad Thyroid Cancer.
Jason Lewis, PhD, comoderator, Radiopharmaceutical
Chemistry Track New Chemy—Other I.
lobert Mach, PhD, modera3r, Radiopharmaceutical
Chemistry Track New
Hhemistry—Oncology I.
Tom Miller, MD, PhD, chair,
Scientific Program.
SCIENTIFIC PAPERS
Farrokh Dehdashti, MD;
Jeff Michalski, MD; Carrien Dence, MS; Barry
Siegel, MD; Michael Welch,
PhD, "Positron tomographic
assessment of androgen
receptors in prostate
carcinoma"
Perry Grigsby, MD, "Gynecologic cancers: clinical and
PET evaluation."

Pilar Herrero, MS; Jeffrey
Baumstark; Deborah
Delano, RN; Robert Gropler, MD, "Improved aerobic
capacity with exercise training in the elderly correlates
with increased myocardial
fatty acid uptake during
dobutamine."
Pilar Herrero, MS; Ziilfia
Kisrieva-Ware, MD, PhD,
MD, PhD; Susan Stellhorn,
RN; Robert Gropler, MD,
"Impact of dobutamine on
myocardial substrate metabolism in type I diabetes."
Pilar Herrero, MS; Zulfia
Kisrieva-Ware, MD, PhD;
Carmen Dence, MS; Paul
Eisenbeis; Terry Sharp;
Robert Gropler, MD,
"Assessment of a mathematical model to measure myocardial glycolysis/oxidation by
PET with 1-carbon-llglucose."
Nobuyuki Oyama, MD,
PhD; Datta Ponde, PhD;
Ryuji Higashikubo, PhD;
Carmen Dence, MS;
Michael Welch, PhD, "In
vitro and in vivo assessment
of 18F-FLT as a proliferation
marker in prostate cancer
tumor model."
Yuan-Chuan Tai, PhD;
Ananya Ruangma, PhD;
Richard Laforest, PhD,
"Performance evaluation of
the microPET® Focus: a second generation small animal
PET system."
Andrei Vlassenko, MD,
PhD; Melissa Rundle; Marcus Raichle, MD; Mark
Mintun, MD, "Lactate injection augments increased
blood flow in physiologically
activated human brain."
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POSTER SESSIONS
Jason Lewis, PhD; Robert
Malyapa, MD, PhD; Ryuji
Higashikubo, PhD; Michael
Welch, PhD, "Histological
comparison of the hypoxia
selective Cu-ATSM and
pimonidazole."
Data Ponde, PhD;
Nobuyuki Oyama, MD,
PhD, Carmen Dence, MS;
Michael Welch, PhD, [I8F]fluoroacetate, an analog of C11 acetate for tumor imaging."
Ananya Ruangma, PhD;
Richard I^aforest, PhD;
Michael Welch, PhD; Mark
Mintun, MD, "Quantitative
evaluation of metal artifacts
on PET data in combined
PET/CT imaging."
Zheng Wang, PhD; Michael
Welch, PhD; Jerrel Rutlin;
Jason Sohn, PhD,
"microPET imaging in
autoimmune uveitis: asymmetric lymphadenopathy in
the secondary lymphoid
system."

INTERNATIONAL SOCIETY
FOR MAGNETIC RESONANCE IN MEDICINE

11th Annual Scientific Meeting & Exhibition
Toronto, Ontario, Canada
July 10-16, 2003

Thomas Conturo, MD,
PhD, organizer, Diffusion/
Perfusion Study Group;
cochair, Diffusion MRI: To
Tensor or Not To Tensor;
cochair, Diffusion Tensor
Imaging Acquisition
Methods; cochair, Diffusion
Tensor Imaging: Clinical
Applications.
ORAL PRESENTATIONS
Thomas Conturo, MD,
PhD, "Numerical analysis of
the feasibility of human
q-space MRI in the case of
finite-duration diffusionencoding gradients."
Melanie Kotys; Erbil Akbudak, PhD; Thomas Conturo, MD, PhD, "Increased
dose dynamic range and temporal resolution of AIFs without additional noise."
POSTER PRESENTATIONS
Erbil Akbudak, PhD;
Joanne Markham, MS;
Melanie Kotys; Glenn Foster, RT; Thomas Conturo,
MD, PhD, "A high spatial
temporal resolution AIF
method for bolus cerebral
perfusion."
Melanie Kotys; Erbil
Akbudak, PhD; Thomas
Conturo, MD, PhD,
"Increased dose dynamic
range and temporal resolution
of AIFs without additional
noise."

AMERICAN ASSOCIATION
FOR CANCER RESEARCH
94"' Annual Meeting
Washington, DC
July 11-14, 2003
Douglas Rowland, PhD,
co-coordinator, 2003-2004
Associate Member Council
Program.
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SYMPOSIA
Continued from page 29
SCHOLAR-IN-TRAINING AWARD
Wen Ping Li, PhD, "A radiolabeled gelainase inhibitor for
metalloproteinase 2 and 9
expression in a murine
melanoma mouse model."
POSTER SESSIONS
Jason Lewis, PhD; Joonyoung Kim, PhD; Michael
Welch, PhD, "Tumoricidal
activity by targeted radiotherapy with the hypoxia specific
agent 64Cu-ATSM is
enhanced by treatment with
2-deoxyglucose."
Weng Ping Li, PhD; Jennifer Sprague; Carolyn
Anderson, PhD, "A radiolabeled gelatinase inhibitor
for PET imaging of amatrix
metalloproteinase 2 and 9
expression in a murine
melanoma mouse model."
Jacob Locke, MD, "Celecoxib enhances cytotoxicity
of heat shock, reduces thermotolerance and modifies
HSF and AP-1 activation."
Girdhar Sharma, PhD; Tej
Pandita, PhD, "Physical and
functional interaction of
HOXB7 with members of
the NHEJ pathway in breast
cancer."

AMERICAN ASSOCIATION
OF PHYSICISTS IN
MEDICINE
45"' Annual Meeting
San Diego, California
August 10-14, 2003
Walter Bosch, DSc, speaker,
Symposium—RT Extensions
to DICOM: Do They Really
Work?
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Joseph Deasy, PhD, chair,
Scientific Session—Other.
Eric Klein, MS, cochair,
Poster Discussion Session—
Educational.
Zuofeng Li, DSc, chair, Scientific Session—IMRT: Planning and Optimization.
Daniel Low, PhD, moderator, Symposium—IMRT:
QA—What Is Enough?
Sasa Mutic, MS, chair,
Poster Discussion Session—
Brachytherapy.
REFRESHER COURSE
Sasa Mutic, MS, "Use of CT
and PET in radiotherapy."
CONTINUING EDUCATION
COURSE
Daniel Low, PhD, "IMRT
system quality assurance."
SCIENTIFIC SESSIONS
Joseph Deasy, PhD; Issam
El Naqa, PhD; Milos Vicic,
PhD, "Validation maps for
bias correction in Monte
Carlo denoising."
Robert Drzymala, PhD;
Zuofeng Li, DSc, "A simple
independent dose calculation
method for verification of
treatment time in Gamma
Knife radio-surgery using integral dose."
Issam El Naqa, PhD;
Joseph Deasy, PhD; Milos
Vicic, PhD, "Denoising of
Monte Carlo dose distributions via locally adaptive
hybrid median filtering."

Issam El Naqa, PhD; Daniel
Low, PhD; Joseph Deasy,
PhD; Michelle Nystrom,
"Automated breathing motion
modeling for 4DCT."
Jian-Yue Jin, PhD; Joseph
Deasy, PhD; Konstantin
Zakaryan, PhD, "Opensource DICOM and GUI tools
for treatment planning
research (WTP)."
Evgeny Kalinin; Joseph
Deasy, PhD, "A method for
fast 3-D IMRT dose calculations: the quadrant infinite
beam (QIB) algorithm."
Fritz Lerma, PhD; Robert
Drzymala, PhD, "Practical
quality assurance of the automatic positioning system on
the Leksell Gamma Knife."
Zuofeng Li, DSc; Sasa
Mutic, MS; Daniel Low,
PhD, "Measured 90 degree
leakage TVLs of photon
beams from an Elekta linear
accelerator."
Daniel Low, PhD, "A novel
polymerizing radiochrome
gel."
Daniel Low, PhD, "Intercomparison of EDR2 and high
sensitivity radiochromic film
for measuring small beams."
Daniel Low, PhD; Milos
Vicic, PhD; Perry Grigsby,
MD; Joseph Deasy, PhD;
Sasa Mutic, MS, "Feasibility
of a novel small animal conformal teletherapy irradiator
(microRT)."

Petr Novak, MSc; Anurag
Singh, MD; Eduardo
Moros, PhD; William
Straube, MS; Andrea Zeug;
Jacob Locke, MD; Robert
Myerson, MD, PhD, "Perfor
mance of a new microPET
compatible small animal
hyperthermia system."
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Milos Vicic, PhD; Daniel
Low, PhD; Perry Grigsby,
MD; Joseph Deasy, PhD,
"Monte-Carlo based optimization of a small animal conformal therapy irradiator
(microRT)."
Sasha Wahab, MD; Daniel
Low, PhD; Issam El Naqa,
PhD; Parag Parikh, MD;
Michelle Nystrom; Jeffrey
Bradley, MD; Sasa Mutic,
MS, "Use of four-dimenional
computed tomography in conformal therapy planning for
lung cancer."
Bruce Whiting, PhD,
"Tomographic reconstructions from incomplete data
(WIP)."
POSTER SESSIONS
Joseph Deasy, PhD; Konstantin Zakaryan, PhD,
"Dose-distance constraints: a
new method for controlling
intensity modulated treatment planning dose
distributions."
Joseph Deasy, PhD; Issa
El Naqa, PhD, "Adaptive
gridding for IMRT dose
calculations."
Jian-Yue Jin, PhD; Sasa
Mutic, MS; Wade Thorst I, j
MD; Daniel Low, PhD;
Fengming Kong, MD; Perry I
Grigsby, MD; James Pur
|
PhD, "Study of field match in
between SMLC-IMRT and
conventional radiotherapy
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ivgeny Kalinin; Issam El
>? ;qa, PhD; Parag Parikh,
I ), "Quantitative spirometiy
f, 4D computed tomography."
|f<Yitz Lerma, PhD; Sasa
lutic, MS; Daniel Low,
PhD, "Peripheral doses
resulting from SMLC MET
delivery."
■aniel Low, PhD; Sasha
ahab, MD; Issam El
"•aqa, PhD; Parag Parikh,
; Michelle Nystrom;
Svgeny Kalinin; Jeffrey
Sradley, MD; Anurag
Singh, MD; Sasa Mutic, MS,
[ "Four-dimensional computed
tomography using a 16-slice
Muardo Moros, PhD; Petr
iMovak, MSc; Prashant Kolluri; William Straube, MS,
"Ultrasound phantoms with
bone inclusions to study the
thermal effect of underlying
i bone on SAR and temperature distributions in superficial hyperthermia."
Petr Novak, MSc; Eduardo
Moros, PhD; William
Straube, MS; Robert Myerson, MD, PhD, "Preclinical
testing of a system for simultaneous ultrasound hyperthermia and radiation beam
therapy."
Konstantin Zakaryan, PhD;
Joseph Deasy, PhD, "Adaptive colormaps for reviewing
dose distributions: 'visual reference' colormaps."

INTERNATIONAL
SYMPOSIUM ON
RADIOPHARMACEUTICAL
CHEMISTRY

MIR Reunion

15°' Annual Meeting
Sydney, Australia
August 10-14, 2003
SCIENTIFIC SESSIONS
Carolyn Anderson, PhD;
Wen Ping Li, PhD; James
Kozlowski; Zhaohui Zhou,
PhD; Daniel Schuster, MD,
"Evaluation of Cu-64-DOTACTT, a MMP-9 inhibitor, as a
potential PET lung inflammation imaging agent."
Heather Bigott, Michael
Welch, PhD, "Synthesis of
rhenium/technetium labeled
estrogen receptor imaging
agents: evaluation using
microPET with technetium94m."
Charles Boswell; Xiankai
Sun, PhD; Carolyn Anderson, PhD, "In vivo stability of
Cu-64-azamacrocyclic complexes: comparison of Teta
and Dota with cross-bridged
chelators."

While in Sydney, Australia, far the International Symposium for Radiopharmaceutical Chemistry, Michael Welch, PhD, cochief of the Division of Radiological Sciences, hosted a reunion for 52 past and present members of the
Radiological Chemistry Laboratory. Left to right: Xiankai Sun, PhD; Jeongsoo
Yoo, PhD; Welch; Yashuisa Fujibayashi, PhD, DMedSci, from Japan's Fukui
Medical University; and Jim Wang, PhD. In 1999, Fujibayashi and Welch
coordinated an academic and cooperative research agreement between MIR
and Fukui University.

Carmen Dence, MS; Joonyoung Kim, PhD; Xiankai
Sun, PhD; Richard Laforest, PhD; Michael Welch,
PhD, "Synthesis, microPET
imaging, biodistributiuon and
dosimetry data of D- and L3[uC]lactic acid."
Jason Lewis, PhD; Jerrel
Rutlin; Lynne Jones;
Michael Welch, PhD, "Cu
64-complexes targeted at
topoisomerase-II, a regulatory
enzyme for DNA topology."

With Welch are (left to right) Jennifer Sprague, Amy Vavere, Andrew
Boswell, and Heather Bigott—Radiological Chemistry Laboratory graduate
students who presented scientific papers at the meeting in Australia.
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SYMPOSIA
Continued from page 31
Richard Laforest, PhD;
Ananya Ruangma, PhD;
Jason Lewis, PhD; Xiankai
Sun, PhD; Michael Welch,
PhD, "microPET imaging of
radiopharmaceuticals labeled
with three copper radionuclides."

Xiankai Sun, PhD; Joel
Garbow, PhD; Jason Lewis,
PhD; Jerrel Rutlin; Carolyn
Anderson, PhD; Michael
Welch, PhD, "Multi-modality
imaging studies on osteolytic
bone metastasis."

Jason Lewis, PhD; JinHwan Kim, PhD; Michael
Welch, PhD, "microPET
imaging of the effects of
tumorcidal 2-deoxyglucose."

Lucie Tang, BscA; Douglas
Rowland, PhD; Debbie Sultan, PhD; Michael Welch,
PhD, "Remote separation
procedure for halogen
production."

Robert Mach, PhD; Wenhua
Chu; Zhude Tu, PhD; Carmen Dence, MS; Michael
Welch, PhD, "["C]PJ34: a
PET radiotracer for imaging
theroleofPARP-lin
necrosis."

Amy Vavere; Michael
Welch, PhD, "microPET
imaging of a titanium-45
labeled titanocene complex to
delineate biodistribution of
titanium anti-cancer drugs."

Paul McQuade, PhD; Jason
Lewis, PhD; Michael Welch,
PhD, "wCu labeling and evaluation of the metallopeptide,
DOTA-reCCMSH(Argl 1),
a cyclized alpha-MSH
analogue."
Douglas Rowland, PhD;
Zhude Tu, PhD; Robert
Mach, PhD; Michael Welch,
PhD, "Investigation of a new
sigma 2 receptor ligand for
detection of breast cancer."
Jennifer Sprague; Xiankai
Sun, PhD; Laura Meyer;
Samuel Achilefu, PhD; Carolyn Anderson, PhD, "In
vivo behavior of copper-64
labeled Y3-octreotate using a
cross-beidged cyclam ligand."
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Zhing Wang, PhD; David
Reichert, PhD; Wouter
Nagengast, "microPET imaging studies of the initiation and
progression of a murine model
of rheumatoid arthritis."

Jeongsoo Yoo, PhD; David
Reichert, PhD; Peter Wolohan, PhD; Michael Welch,
PhD, "Regioselectively Nsubstituted cyclens: synthesis,
biodistribution, log P and
modeling."
POSTER SESSIONS
Mohammed Al-Qahtani,
PhD; Michael Welch, PhD,
"A new synthesis procedure
of [18F]FFNP for in vivo imaging of progestin receptors."
Pilar Herrero, MS; Zulfia
Kisrieva-Ware, MD, PhD;
Carmen Dence, MS; Paul
Eisenbeis; Terry Sharp;
Robert Gropler, MD,
"Assessment of a mathematical model to measure myocardial glycolysis/oxidation by
PET and I-carbon-11-glucose."
Paul McQuade, PhD; Lynne
Jones; Michael Welch,
PhD, ""mTC and MCu labeled
annexin-V, positron emitting
radiopharmaceuticals to
study apoptosis."

Paul McQuade, PhD; Jason
Lewis, PhD, Investigation
into improved imaging agents
for cardiovascular and neurologic hypoxia."
David Reichert, PhD; Zhi»
Wang, PhD, "Approaches
to the in vivo PET imaging
of T cells in adoptive
immunotherapy."
Xiankai Sun, PhD; Carolyn
Anderson, PhD, "In vivo
evaluation of indium111-labeled cross-bridged
tetraazamacrocyclic ligands."
Lucie Tang, BScA; Gregory
Gaehle; Jason Lewis, PhD;
Michael Welch, PhD, "Auto
mated separation, purification j
and labeling systems for copper isotopes (^Cu, 61Cu, MCu)."
Zhude Tu, PhD; Suwanna
Vangveravong; Carmen
Dence, MS; Robert Mach,
PhD, "Conformationallyflexible benzamide analogues
as dopamine D3 receptor
imaging agents for PET and
SPECT."

Special Award
At the April meeting of the
American Radium Society
(ARS), Robert Malyapa,
MD, PhD, assistant professor of radiation oncology,
received the ARS Young
Oncologist Essay Award
for his talk on "ERK lh
activation is associated
with poor prognosis in
hypoxic cancers of the
uterine cervix." At left is
Frank Wilson, MD, ARS
president.
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(Seated, left to right) Doctors Andrew Bierhals; Cynthia Santillan; Heather Byer; Wincha Chong; Scott
Andersen, diagnostic radiology chief resident; Naveen Parti, diagnostic radiology chief resident; Gilbert
Jost, director of the Institute; Christine Menias, assistant director, Diagnostic Radiology Residency
Program; Robert Kadner, diagnostic radiology chief resident; Jason Bronfman; Ronald Gerstle;
Kianoush Rezaei; Christian Schmitt. (Second row) Doctors Vladislav Gorengaut, Nelson Elkins, Yuliya
Lakhman, Markus Lammle, David Mueller, Creed Rucker, Karun Sharma, Aamer Farooki, Anand Singh,
Gregory Sanders, Ryan Murtagh, Kevin Lee, David Johnston, Daniel Wessell, Franklin Marden, Cary
Shlimovitz, Jason Wagner, Jayson St. Jacques, Brett Gratz, Howard Harvin, Ningmei Hu, Michelle
Dorsey, Bonnie Joe, Jennifer Lee, Tammie Benzinger. (Third row) Doctors Ashesh Parikh, Scott Bolton,
Krishna Thirumala, Ryan Cook, Jason Kerr, Archie McGowan, Merhdad Sehizadeh, Srinivasa Prasad,
Michael Todora, Edward Lee, Alf Hutter, Avi Mazumdar, John Agles, Peter Chuang, Jason Oliphant,
Vikram Patel.
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